Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours-Reference-Cited by-同舟云学术

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours

Published:1999-06-11 Issue:9 Volume:80 Page:1392-1399
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Fosså S D,Stenning S P,Gerl A,Horwich A,Clark P I,Wilkinson P M,Jones W G,Williams M V,Oliver R T,Newlands E S,Mead G M,Cullen M H,Kaye S B,Rustin G J S,Cook P A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6690534.pdf

Reference22 articles.

1. Baniel, J., Foster, R. S., Gonin, R., Messemer, J. E., Donohue, J. P. & Einhorn, L. H. (1995). Late relapse of testicular cancer. J Clin Oncol 13: 1170–1176.

2. Beyer, J., Kramar, A., Mandanas, R., Linkesch, W., Greinix, A., Droz, J. P., Pico, J. L., Diehl, A., Bokemeyer, C., Schmoll, H. J., Nichols, C. R., Einhorn, L. H. & Siegert, W. (1996). High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables [see comments]. J Clin Oncol 14: 2638–2645.

3. Broun, E. R., Nichols, C. R., Kneebone, P., Williams, S. D., Loehrer, P. J., Einhorn, L. H. & Tricot, G. J. (1992). Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 117: 124–128.

4. Cassidy, J., Lewis, C. R., Kaye, S. B. & Kirk, D. (1992). The changing role of surgery in metastatic non-seminomatous germ cell tumour. Br J Cancer 65: 127–129.

5. Gerl, A., Clemm, C., Schmeller, N., Hartenstein, R., Lamerz, R. & Wilmanns, W. (1995). Prognosis after salvage treatment for unselected male patients with germ cell tumours. Br J Cancer 72: 1026–1032.

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study;Medicine;2024-02-23

2. Testicular cancer in 2023: Current status and recent progress;CA: A Cancer Journal for Clinicians;2023-11-10

3. A decade in focus: mixed germ cell tumors with choriocarcinoma components;Annals of Medicine & Surgery;2023-09-20

4. Testicular Malignancy;Men’s Health and Wellbeing;2022

5. Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors;Cancer Medicine;2021-03-05